Biologics represent the cutting-edge of biomedical research, and biosimilars present an enormous opportunity to provide affordable access to these advanced therapies. Biosimilars are intended to increase patients’ access to biologics as they are priced lower than branded, novel biologics and may further lead to the competitive pricing of the original biologic.
Biosimilars can ensure a greater and more equitable access to biologic therapies and to healthcare generally. Biosimilars are projected to generate US$290 billion in savings around the world through 2027, according to IQVIA’s Global Use of Medicines Report for 2023.
Biocon Biologics is today one of the frontrunners in the global biosimilars industry, working to provide patients access to affordable biologics and enable health equity worldwide.
DATE AND TIME:
- Date: 23 & 24 October 2026
- Time: 9:00 AM – 12:00 PM
- Venue: Biocon Sdn Bhd (No. 1, Jalan Bioteknologi 1, Kawasan Perindustrian SiLC, 79200 Iskandar Puteri, Johor, Malaysia)
- Registration: Please find the registration link in the comment section
For More JOB Updates Join Our Whatsapp Group CLICK HIRE
JOB DETAILS:
Opportunities:
Drug Substance, Drug Product, Quality Assurance (QA), Quality Control (QC), Engineering, Research & Development, Supply Chain, Logistic
DOCUMENTS:
1) Updated Resume/CV
2) Highest Education Certificate / Completion Letter
Who Can Apply?
1) Fresh graduates from the following disciplines:
Engineering (all disciplines)
Science (all disciplines)
Biology
Biotechnology
Business Administration/ Management
Logistics / Supply Chain Management
For More JOB Updates Join Our Whatsapp Group CLICK HIRE
